The levels of evidence supporting the recommendations (I-IV) and grades of recommendations (A-D and clinical practice points [CPP]) are defined at the end of the "Major Recommendations" field.
The original guideline document also includes a consumer rating that identifies aspects of care considered to be critical from a patient perspective.
Dysphagia
Patients should be screened for swallowing deficits before being given food, drink or oral medications. Screening should be undertaken by personnel specifically trained in swallowing screening. (Grade C, Level I [Perry & Love, 2001; Martino, Pron, & Diamant, 2000])
Patients should be screened within 24 hours of admission. (CPP)
Patients who fail the swallowing screening should be referred to a speech pathologist for a comprehensive assessment. (CPP)
Nutrition
Close monitoring of hydration status and appropriate fluid supplementation should be used to treat or prevent dehydration. (Grade B; Level I [Hodgkinson, Evans, & Wood, 2003])
All patients with acute stroke should be screened for malnutrition. (Grade B; Level II [Dennis et al., "Routine oral nutritional," 2005])
Those who are at risk of malnutrition, including those with dysphagia, should be referred to a dietitian for assessment and ongoing management. Assessment of nutritional status should include the use of validated nutrition assessment tools or measures. (CPP)
Nutritional supplementation should be offered to people whose nutritional status is poor or deteriorating. (Grade A; Level I [Milne, Avenell, & Potter, 2006])
Nasogastric (NG) feeding is the preferred method during the first month post stroke for people who do not recover a functional swallow. (Grade B; Level II [Dennis et al., "Effect of the timing and method," 2005])
Food intake should be monitored for all people with acute stroke. (CPP)
Early Mobilisation
Patients should be mobilised as early and as frequently as possible. (Grade B; Level II [Indredavik et al., 1999])
After assessment the physiotherapist should advise staff and carers of appropriate mobilising and transfer techniques. (CPP)
Early Therapy for Difficulties with Activities of Daily Living (ADL)
Patients with difficulties in occupational performance in daily activities should be treated by an occupational therapist or a specialist multidisciplinary team that includes an occupational therapist. (Grade B; Level I [Langhorne et al., 2002; Legg, Drummond, & Langhorne, 2006])
Patients with confirmed difficulties in occupational performance in personal tasks, instrumental activities, vocational activities or leisure activities should have a management plan formulated and documented to address these issues. (CPP)
The occupational therapist should advise staff and carers on techniques and equipment to maximise outcomes relating to functional performance in daily activities, sensorimotor, perceptual and cognitive capacities. (CPP)
Cognition and Perception
All patients should be screened for cognitive and perceptual deficits using a validated screening tool. (CPP)
Patients identified during screening should undertake full assessment and management by an appropriately trained health professional. (CPP)
Communication
All patients should be screened for communication deficits using a validated screening tool. (Grade C, Level I [Salter et al., 2006)])
Those with suspected communication difficulties should receive formal assessment by a speech pathologist. (CPP)
Patients with communication difficulties should be treated as early and as frequently as possible. (Grade C, Level I [Bhogal, Teasell, & Speechley, 2003] & Level III-2 [Robey, 1998])
All written health information should be available in an aphasia friendly format. (Grade D, Level IV [Rose, Worrall, & McKenna, 2003])
The speech pathologist should advise staff and family/carers of appropriate communication techniques. (Grade C, Level II [Kagan et al., 2001; Wertz et al., 1986])
Incontinence
All patients with suspected continence difficulties should be assessed by trained personnel using a structured functional assessment. (Grade B; Level II [Thomas et al., 2005])
A portable bladder ultrasound scan can be used to assist in diagnosis and management of urinary incontinence. (Grade B; Level I [Martin et al., 2006]).
Patients with confirmed continence difficulties should have a continence management plan formulated and documented. (Grade C; Level II [Thomas et al., 2005])
The use of indwelling catheters should be avoided as an initial management strategy. (CPP)
A post discharge continence management plan should be developed with the patient and carer prior to discharge and should include how to access continence resources in the community. (CPP)
Mood
Patients with suspected altered mood (e.g., depression, anxiety, emotional lability) should be assessed by trained personnel using a standardised scale. (Grade B; Level II & Level III-1 [Joubert et al., 2006; Aben et al., 2002; Lincoln et al., 2003; Williams et al., 2005; Benaim et al., 2004; Watkins et al., 2007])
Patients with stroke may be managed using a case management model after discharge to reduce post stroke depression. If used, services should incorporate education of the recognition and management of depression, screening and assistance to coordinate appropriate interventions via a medical practitioner. (Grade C; Level II [Joubert et al., 2006; Williams et al., 2007])
Routine use of antidepressants to prevent poststroke depression is not currently recommended. (Grade B; Level I [Anderson, Hackett, & House, 2004])
Antidepressants may be used for people with emotional lability. (Grade B; Level I [House et al., 2004])
Patients with depression or anxiety may be treated with antidepressants and/or psychological interventions to improve mood. (Grade B; Level I [Hackett, Anderson, & House, 2004])
Definitions:
Levels of Evidence
Level |
Intervention |
Diagnosis |
Prognosis |
Aetiology |
Screening |
I |
A systematic review of Level II studies |
A systematic review of Level II studies |
A systematic review of Level II studies |
A systematic review of Level II studies |
A systematic review of Level II studies |
II |
A randomised controlled trial |
A study of test accuracy with: an independent, blinded comparison with a valid reference standard, among consecutive patients with a defined clinical presentation |
A prospective cohort study |
A prospective cohort study |
A randomised controlled trial |
III-1 |
A pseudo-randomised controlled trial (i.e., alternate allocation or some other method) |
A study of test accuracy with: an independent, blinded comparison with a valid reference standard, among consecutive patients with a defined clinical presentation |
All or none |
All or none |
A pseudo-randomised controlled trial (i.e., alternate allocation or some other method) |
III-2 |
A comparative study with concurrent controls:
- Non-randomised experimental trial
- Cohort study
- Case-control study
- Interrupted time series without a parallel control group
|
A comparison with a reference standard that does not meet the criteria required for Level II and Level III-1 evidence |
Analysis of prognostic factors amongst untreated control patients in a randomised controlled trial |
A retrospective cohort study |
A comparative study with concurrent controls:
- Nonrandomised, experimental trial
- Cohort study
- Case-control study
|
III-3 |
A comparative study without concurrent controls:
- Historical control study
- Two or more single arm study
- Interrupted time series without a parallel control group
|
Diagnostic case-control study |
A retrospective cohort study |
A case-control study |
A comparative study without concurrent controls:
- Historical control study
- Two or more single arm study
|
IV |
Case series with either post-test or pre-test/post-test outcomes |
Study of diagnostic yield (no reference standard) |
Case series or cohort study of patients at different stages of disease |
A cross-sectional study |
Case series |
Grading of Recommendations
Grade |
Description |
A |
Body of evidence can be trusted to guide practice |
B |
Body of evidence can be trusted to guide practice in most situations |
C |
Body of evidence provides some support for recommendation(s) but care should be taken in its application |
D |
Body of evidence is weak and recommendation must be applied with caution |
Clinical Practice Points |
CPP |
Recommended best practice based on clinical experience and expert opinion |